Key takeaways
- BPC-157 and TB-500 are commonly studied together in in-vitro regeneration models.
- BPC-157 is referenced around angiogenesis; TB-500 around cell migration.
- Both are ≥99% HPLC-verified reference standards with independent batch analyses.
Two peptides, one research theme
BPC-157 and TB-500 are among the most-referenced peptides in regeneration research, and they are frequently studied as a pair in in-vitro tissue-repair models. Both are supplied as lyophilized reference standards for laboratory use only.
How each is characterised
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide (MW 1419.5 g/mol) referenced around angiogenesis and extracellular-matrix signalling. TB-500, a fragment of Thymosin β4, is examined for actin-binding and cell-migration pathways. Neither carries any human-use claim.
Verification and documentation
Both compounds are released only after HPLC purity verification and LC-MS identity confirmation, each with a batch-specific Certificate of Analysis tied to the vial.
Frequently asked
Research use only. This reference material is for in-vitro laboratory research. Not for human or animal consumption.
